Physiologically Based Pharmacokinetic Modeling is a sophisticated approach in pharmacodynamics that integrates physiological parameters to predict drug behavior within the body. It considers factors such as organ function, blood flow, and tissue composition to simulate drug concentration changes over time accurately. Unlike traditional pharmacokinetic models, PBPK offers a more comprehensive understanding of drug interactions, absorption, distribution, metabolism, and excretion.
PBPK models enhance drug development by providing insights into variability among individuals and populations, aiding in dose optimization and safety assessments. They play a pivotal role in predicting drug-drug interactions and supporting regulatory decisions. By incorporating physiological realism, PBPK modeling contributes to refining dosage regimens, minimizing adverse effects, and expediting the development of new therapeutic agents. As a powerful tool, PBPK modeling continues to revolutionize the field of pharmacodynamics, fostering more precise and personalized approaches to drug design and administration.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia